Condition
Peripheral Vertigo
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 3 (2)
P 4 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05586763Phase 3RecruitingPrimary
Comparison of Efficacy of Metoclopramide , Promethazine and Prochloroperazine in the Treatment of Vertigo.
NCT05676216Not ApplicableUnknownPrimary
Sodium Bicarbonate for Acute Peripheral Vertigo
NCT01890538Phase 4CompletedPrimary
Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo
NCT01827293Phase 3CompletedPrimary
Promethazine vs. Lorazepam for Treatment of Vertigo
Showing all 4 trials